[NP_P11] Poster Session 11

Sun. Oct 13, 2019 4:40 PM - 6:10 PM Poster Hall (Multi-purpose Hall)

座長：小田垣雄二（埼玉医科大学医学部神経精神科・心療内科）

10月12日（土）　17:25～18:10　ポスター会場（福岡国際会議場 2階多目的ホール）
10月13日（日）　16:40～18:10　ポスター会場（福岡国際会議場 2階多目的ホール）

+Add all to schedule

4:40 PM - 4:45 PM

[NP-P11-1] The Efficacy and Safety of Lurasidone in Acutely Psychotic Subjects with Schizophrenia：A 6-Week, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study (JEWEL Study)

^○Masaomi IYO¹, Jun ISHIGOOKA², Masatoshi NAKAMURA³, Reiko SAKAGUCHI⁴, Keisuke OKAMOTO⁵, Tadashi NOSAKA⁶, Teruhiko HIGUCHI ^{7, 8} (1. Department of Psychiatry, Graduate School of Medicine, Chiba University, Japan, 2. Institute of CNS Pharmacology, Japan, 3. Data Science, Sumitomo Dainippon Pharma Co., Ltd., Japan, 4. Clinical Research, Sumitomo Dainippon Pharma Co., Ltd., Japan, 5. Clinical Operations, Sumitomo Dainippon Pharma Co., Ltd., Japan, 6. Medical Affairs, Sumitomo Dainippon Pharma Co., Ltd., Japan, 7. Japan Depression Center, Japan, 8. The National Center of Neurology and Psychiatry, Japan)

4:45 PM - 4:50 PM

[NP-P11-2] Withdraw

4:50 PM - 4:55 PM

[NP-P11-3] Efficacy of Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled 6-week Study (ELEVATE study)

^○Tadafumi KATO¹, Jun ISHIGOOKA², Mari MIYAJIMA³, Kei WATABE⁴, Takahiro MASUDA⁵, Teruhiko HIGUCHI^{6, 7} (1. Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Center for Brain Science, Tokyo, Japan, 2. Institute of CNS Pharmacology, Japan, 3. Clinical Research, Sumitomo Dainippon Pharma Co., Ltd., Japan, 4. Data Science, Sumitomo Dainippon Pharma Co., Ltd., Japan, 5. Medical Affairs, Sumitomo Dainippon Pharma Co., Ltd., Japan, 6. Japan Depression Center, Japan, 7. The National Center of Neurology and Psychiatry, Japan)

4:55 PM - 5:00 PM

[NP-P11-4] Safety and Tolerability of Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled 6-week Study (ELEVATE study)

^○Teruhiko HIGUCHI^{1, 2}, Jun ISHIGOOKA³, Mari MIYAJIMA⁴, Kei WATABE⁵, Takahiro MASUDA⁶, Tadafumi KATO⁷ (1. Japan Depression Center, Japan, 2. The National Center of Neurology and Psychiatry, Japan, 3. Institute of CNS Pharmacology, Japan, 4. Clinical Research, Sumitomo Dainippon Pharma Co., Ltd., Japan, 5. Data Science, Sumitomo Dainippon Pharma Co., Ltd., Japan, 6. Medical Affairs, Sumitomo Dainippon Pharma Co., Ltd., Japan, 7. Laboratory for Molecular Dynamics of Mental Disorders, RIKEN Center for Brain Science, Japan)

5:00 PM - 5:05 PM

[NP-P11-5] Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study (ELEVATE extension study)

^○Jun ISHIGOOKA¹, Teruhiko HIGUCHI^{2, 3}, Mari MIYAJIMA⁴, Kei WATABE⁵, Takahiro MASUDA⁶, Tadafumi KATO⁷ (1. Institute of CNS Pharmacology, Japan, 2. Japan Depression Center, Japan, 3. The National Center of Neurology and Psychiatry, Japan, 4. Clinical Research, Sumitomo Dainippon Pharma Co., Ltd., Japan, 5. Data Science, Sumitomo Dainippon Pharma Co., Ltd., Japan, 6. Medical Affairs, Sumitomo Dainippon Pharma Co., Ltd., Japan, 7. Laboratory for Molecular Dynamics of Mental Disorders RIKEN Center for Brain Science, Japan)

5:05 PM - 5:10 PM

[NP-P11-6] Continuation of new antidepressant drugs in the second-line treatment of major depression:A multisite collaborative randomized flexible-dose open-label clinical trial

^○Yuma Yokoi¹, Naoki Yoshimura¹, Kenji Hatano¹, Takayuki Abe², Atsuo Nakagawa², Ken Inada³, Tomiki Sumiyoshi¹, Koichiro Watanabe⁴, Takashi Tsuboi⁴, Yumiyo Morokawa⁵, Akira Iwanami⁶, Masaru Mimura⁷, Toshiaki Furukawa⁸, Gentaro Nishioka⁹, Hideki Oi¹, Kazuyuki Nakagome¹ (1. National Center of Neurology and Psychiatry, 2. Keio University Hospital Clinical and Translational Research Center, 3. Department of Psychiatry, Tokyo Women’s Medical University, 4. Department of Neuropsychiatry, Kyorin University School of Medicine, 5. Seimou Hospital Clinical Medicine Research Center, 6. Department of Psychiatry, Showa Karasuyama Hospital, 7. Department of Neuropsychiatry, Keio University School of Medicine, 8. Departments of Health Promotion and Human Behavior and of Clinical Epidemiology Kyoto University Graduate School of Medicine, 9. Kawaguchi Clinic)